Wolverine Asset Management’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-108,999
Closed -$1.06M – 2492
2022
Q3
$1.06M Buy
108,999
+107,999
+10,800% +$1.05M 0.01% 763
2022
Q2
$9K Buy
+1,000
New +$9.7K ﹤0.01% 2020

Other funds holding DALS

Wolverine Asset Management's DALS Position: Q4 2022 in Review

Wolverine Asset Management sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q4 2022, closing a stake of 108,999 shares — an estimated $1.06M sold.

Wolverine Asset Management first reported a position in DALS in Q2 2022 and held it in 2 quarters. The position peaked at $1.06M in Q3 2022. 47 funds tracked by Wall St. Rank hold DALS as of Q4 2022.

  • Wolverine Asset Management reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q4 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 108,999 DA32 Life Science Tech Acquisition Corp shares in Q4 2022, an estimated $1.06M.
  • Wolverine Asset Management first reported a position in DA32 Life Science Tech Acquisition Corp in Q2 2022 and held it in 2 quarters.
  • Wolverine Asset Management's DA32 Life Science Tech Acquisition Corp position peaked at $1.06M in Q3 2022.
  • 47 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q4 2022.

Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.